Derek S. McCandless
Net Worth
Last updated:
What is Derek S. McCandless net worth?
The estimated net worth of Mr. Derek S. McCandless is at least $29,664,876 as of 1 Jun 2021. He owns shares worth $7,308,299 as insider, has earned $12,308,357 from insider trading and has received compensation worth at least $10,048,220 in Cencora.
What is the salary of Derek S. McCandless?
Mr. Derek S. McCandless salary is $717,730 per year as Senior Vice President of Legal, Gen. Counsel & Sec. in Cencora.
How old is Derek S. McCandless?
Mr. Derek S. McCandless is 54 years old, born in 1971.
What stocks does Derek S. McCandless currently own?
As insider, Mr. Derek S. McCandless owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cencora (COR) | Senior Vice President of Legal, Gen. Counsel & Sec. | 24,943 | $293 | $7,308,299 |
What does Cencora do?
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Derek S. McCandless insider trading
Cencora
Mr. Derek S. McCandless has made 40 insider trades between 2011-2021, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of COR stock worth $361,929 on 1 Jun 2021.
The largest trade he's ever made was exercising 45,000 units of COR stock on 29 Jul 2015. As of 1 Jun 2021 he still owns at least 24,943 units of COR stock.
Cencora key executives
Cencora executives and other stock owners filed with the SEC:
- Mr. Brian P. Warren (55) Senior Vice President of Devel. & Product Engineering
- Mr. Derek S. McCandless (54) Senior Vice President of Legal, Gen. Counsel & Sec.
- Mr. Jeffrey S. Finnin (62) Chief Financial Officer & Treasurer
- Mr. Paul E. Szurek (64) Pres, Chief Executive Officer & Director
- Mr. Steven J. Smith (60) Chief Revenue Officer